AzTrials
AzTrials

Peripheral Arterial DiseaseNCT07250776

Effects of Body Awareness Therapy on Functional Capacity, With Peripheral Artery Disease

A study testing Body Awareness Therapy and Conventional Physiotherapy in people with Peripheral Arterial Disease, run by Karadeniz Technical University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Patients will be divided into two groups. One group will receive only a conventional physiotherapy program. The conventional physiotherapy program included breathing and aerobic exercises, energy conservation techniques, and activities of daily living. Read more about this study

Who is it for?
Any age
Conditions the study is for
Peripheral Arterial Disease
What is being tested?
Body Awareness Therapy and Conventional Physiotherapy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
51 participants
Where
1 siteTurkey (Türkiye)
Study dates
30 Jun 2025to 17 Nov 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Diagnosis of Peripheral Artery Disease (PAD) (confirmed by Doppler ultrasonography or Ankle-Brachial Index (ABI) ≤ 0.90).
  • Being between 40 and 75 years of age.
  • Having Stage II-III PAD.
  • Being able to walk independently or with minimal support.
  • Being fit for exercise with cardiac or pulmonary functions.
  • Having a cognitive level sufficient to participate in body awareness training.
  • Having a stable cardiovascular status (not having had an acute cardiac event, myocardial infarction, or stroke) within the last 6 months.
  • Agreeing to actively participate in the study and signing the informed consent form.

Who cannot join

  • Having Stage IV PAD.
  • Individuals unable to carry out daily activities due to severe rest pain.
  • Serious cardiovascular, pulmonary, neurological, cognitive, or musculoskeletal diseases
  • Those who have had a myocardial infarction, stroke, or surgery within the last 6 months.
  • Uncontrolled hypertension, heart failure, respiratory failure, or dependence on oxygen support
  • Active infection or inflammatory diseases
  • Uncontrolled diabetes or renal failure
  • Missed 2 consecutive sessions

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Karadeniz Technical University, Farabi Hospital

    Trabzon, Türkiye, 34033

Other trials in Turkey (Türkiye)

About this study

Official title: Effects of Body Awareness Therapy on Physical Psychosocial Outcomes in Peripheral Artery Disease: A Randomized Controlled Trial

Patients will be divided into two groups. One group will receive only a conventional physiotherapy program. The conventional physiotherapy program included breathing and aerobic exercises, energy conservation techniques, and activities of daily living. The exercises were supervised once a week and unsupervised for six days. The program was administered 1 x 7 x 8 hours/day/week.

The experimental group received Body Awareness therapy in addition to the conventional physiotherapy program. The exercise content included relaxation exercises, breathing exercises, floor exercises for trunk and pelvic movements, and extremity movements. Body Awareness Therapy was also administered 1 x 7 x 8 hours/day/week.

Being tested
Body Awareness Therapy, Conventional Physiotherapy
Keywords
Body Awareness Therapy, rehabilitation
Medical subject headings
Peripheral Arterial Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Body Awareness TherapyProcedure or surgery

    The Body Awareness Therapy content included relaxation exercises, breathing exercises, floor exercises for trunk and pelvic movements, and extremity movements. Body Awareness Therapy was also administered 1 x 7 x 8 hours/day/week.

  • Conventional PhysiotherapyProcedure or surgery

    The conventional physiotherapy program included breathing and aerobic exercises, energy conservation techniques, and activities of daily living. The exercises were supervised once a week and unsupervised for six days. The program was administered 1 x 7 x 8 hours/day/week.

Study groups in NCT07250776
Study groupRoleWhat they receive
Body Awareness Therapy GroupExperimentalPhysiotherapy and body awareness therapy were applied
Receives: Procedure: Body Awareness Therapy; Procedure: Conventional Physiotherapy
Conventional Therapy GroupActive comparatorPhysiotherapy was applied.
Receives: Procedure: Conventional Physiotherapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. 6-Minute Walk Test

    Measured: Baseline

  2. 6-Minute Walk Test

    Measured: End of the 8th week

  3. Muscle Strength

    For Quadriceps and Hamstring muscles with hand-held dynamometer

    Measured: Baseline

  4. Muscle Strength

    For Quadriceps and Hamstring muscles with hand-held dynamometer

    Measured: End of the 8th week

  5. Body Awareness Questionnaire (BAQ)

    The total score on the scale is between 18 and 126. A high score indicates a high level of awareness.

    Measured: Baseline

  6. Body Awareness Questionnaire (BAQ)

    The total score on the scale is between 18 and 126. A high score indicates a high level of awareness.

    Measured: End of the 8th week

  7. Visual Analog Scale

    Durnig resting, at Night and After Training. A high score indicates a high level of pain intensity.

    Measured: Baseline

  8. Visual Analog Scale

    Durnig resting, at Night and After Training. A high score indicates a high level of pain intensity.

    Measured: End of the 8th week

  9. Claudication Onset Distance

    Measured: Baseline

  10. Claudication Onset Distance

    Measured: End of the 8th week

  11. Absolute Claudication Distance

    Measured: Baseline

  12. Absolute Claudication Distance

    Measured: End of the 8th week

  13. Pain Catastrophizing Scale

    The total score ranges from 0 to 52. Higher scores indicate greater levels of pain catastrophizing.

    Measured: Baseline

  14. Pain Catastrophizing Scale

    The total score ranges from 0 to 52. Higher scores indicate greater levels of pain catastrophizing.

    Measured: End of the 8th week

  15. Pittsburgh Sleep Quality Index

    The total score ranges from 0 to 21. Higher scores reflect poorer sleep quality.

    Measured: Baseline

  16. Pittsburgh Sleep Quality Index

    The total score ranges from 0 to 21. Higher scores reflect poorer sleep quality.

    Measured: End of the 8th week

  17. Multidimensional Scale of Perceived Social Support

    The total score ranges from 12 to 84. Higher scores indicate greater perceived social support.

    Measured: Baseline

  18. Multidimensional Scale of Perceived Social Support

    The total score ranges from 12 to 84. Higher scores indicate greater perceived social support.

    Measured: End of the 8th week

  19. Perceived Stress Scale (PSS-10)

    The total score ranges from 0 to 40. Higher scores indicate higher perceived stress.

    Measured: Baseline

  20. Perceived Stress Scale (PSS-10)

    The total score ranges from 0 to 40. Higher scores indicate higher perceived stress.

    Measured: End of the 8th week

  21. Hospital Anxiety and Depression Scale

    Each subscale (Anxiety and Depression) ranges from 0 to 21. Higher scores indicate greater anxiety or depressive symptoms.

    Measured: Baseline

  22. Hospital Anxiety and Depression Scale

    Each subscale (Anxiety and Depression) ranges from 0 to 21. Higher scores indicate greater anxiety or depressive symptoms.

    Measured: End of the 8th week

  23. Tampa Scale of Kinesiophobia

    The total score ranges from 17 to 68. Higher scores indicate greater fear of movement.

    Measured: Baseline

  24. Tampa Scale of Kinesiophobia

    The total score ranges from 17 to 68. Higher scores indicate greater fear of movement.

    Measured: End of the 8th week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Nov 2025
  2. Study start30 Jun 2025
  3. Primary completion17 Nov 2025
  4. Study completion17 Nov 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
51 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07250776
Sponsor's protocol ID
2025/68
Status last verified
Nov 2025
First submitted
18 Nov 2025
Last updated
26 Nov 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Karaca S, Senocak E, Yuruk MA. Body Awareness Therapy in Peripheral Arterial Disease: A Randomized Controlled Trial. Pain Manag Nurs. 2026 May 17:S1524-9042(26)00162-1. doi: 10.1016/j.pmn.2026.04.023. Online ahead of print.

    PubMed 42144309

Questions about this trial

What is this clinical trial studying?

A study testing Body Awareness Therapy and Conventional Physiotherapy in people with Peripheral Arterial Disease, run by Karadeniz Technical University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

6-Minute Walk Test (time frame: Baseline). The study lists 24 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07250776, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Nov 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in